MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering ...

HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure ...

Interim results from a study in China suggest ivonescimab may reduce the risk of death versus Keytruda, but the difference ...

Shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX, TSX:BCT) surged 80% after the company announced a confirmed 100% resolution of lung metastasis in a breast cancer patient treated with Bria-OTS, its ...

Variable frequency drives (VFDs) are used in many industrial applications to improve energy efficiency and provide precise ...

GRAFORD — Passionate supporters of the Lone Camp Volunteer Fire Department coaxed open a window on Wednesday to show evidence their rebuilding efforts will succeed. The 60-day grace period from ...

(RTTNews) - Eli Lilly and Company (LLY) Thursday reported topline data from Phase 3 ACHIEVE-1 study of orforglipron in adults with type 2 diabetes. The study met its primary goal. ACHIEVE-1 is the ...

Clinical trial registration: ClinicalTrials.gov, identifier NCT05458180. This prospective, single-arm, open-label, multicenter, dose-escalation, phase I study (ClinicalTrials.gov identifier ...

Inpex has commenced the front-end engineering and design phase for the so-called onshore ... The floater will have gas processing capacity of up to 1.8 billion cubic feet per day of gas and ...

The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for EGFR+ solid tumors. The FDA has cleared the investigational new drug (IND) ...

School of Physics and Wuhan National High Magnetic Field Center, Huazhong University of Science and Technology, Wuhan 430074, China ...